Wolters Kluwer to buy AgileMD for up to $100 million for clinical AI

Representative image: fernandozhiminaicela / Pixabay
Wolters Kluwer agreed on 13 November 2026 to buy AgileMD, a clinical decision support firm, for up to $100 million: $40 million upfront, $60 million later.
What Happened
Wolters Kluwer, the information-services company behind the UpToDate medical reference used by doctors, has agreed to buy AgileMD, a San Francisco company whose software helps hospitals follow clinical guidelines and spot patients who are getting worse, for up to $100 million. The company announced the deal on Friday, 13 November 2026. It will pay $40 million in cash upfront and up to $60 million more later, depending on performance. Wolters Kluwer said it expects the deal to close in the first quarter of 2027 or sooner, subject to customary conditions and government approvals.
Wolters Kluwer: key facts
- Buyer: Wolters Kluwer Health; target: AgileMD, San Francisco.
- Price: up to $100 million, made up of $40 million upfront and up to $60 million in performance-based deferred payments.
- Announced: 13 November 2026; closing expected in the first quarter of 2027 or sooner.
- AgileMD Pathways turns a hospital's own clinical guidelines into steps that staff follow inside electronic health record (EHR) systems.
- eCART is AgileMD's real-time surveillance engine that predicts when hospital patients may deteriorate; it is cleared by the US Food and Drug Administration through the 510(k) process.
- UpToDate Expert AI, launched in September 2025, is used by more than 2,700 US hospitals and health systems, over 95% of US UpToDate Enterprise Edition customers, according to Wolters Kluwer.
- Wolters Kluwer expects the deal to earn a return at or above its 8% after-tax cost of capital within three to five years, with an immaterial effect on adjusted earnings.
Wolters Kluwer: why it matters
This deal is a clear example of what digital transformation means in healthcare. A reference tool like UpToDate tells a doctor what the evidence says. Software like AgileMD's sits inside the hospital's own record system and turns that knowledge into action at the bedside: prompting the right next step for a patient, or warning nurses that a patient's numbers suggest trouble before it becomes an emergency. By combining the two, Wolters Kluwer is trying to move from selling information to selling tools that shape decisions during care.
The move also reflects a wider shift in enterprise software. Many companies that built businesses on content and data are now buying firms that put that content into workflows, often with AI. Integration into the EHR is the key point, because it puts guidance in the system staff already use to record care.
The structure of the payment is cautious. Only 40% of the maximum price is paid upfront; the rest depends on how AgileMD performs. This shares risk between buyer and seller and suggests that Wolters Kluwer is paying mainly for future growth. The company's statement that the deal will have an immaterial effect on adjusted earnings signals that it is small relative to Wolters Kluwer's overall business.
For Indian readers, the deal shows where hospital technology is heading: evidence, AI and workflow sold as one package. Hospitals that are moving to electronic records may see such combined tools offered to them too.
Peepals calculation: The upfront payment is 40% of the maximum price ($40 million ÷ $100 million), leaving 60% tied to performance. If 2,700 hospitals and health systems are more than 95% of UpToDate Enterprise Edition customers in the US, the total US Enterprise Edition base is fewer than about 2,842 (2,700 ÷ 0.95). Our calculation from the reported figures.
| Item | Amount |
|---|---|
| Upfront cash | $40 million |
| Performance-based deferred payment | Up to $60 million |
| Maximum total | Up to $100 million |
Impact
Short-term: The deal goes through regulatory review, with closing expected by early 2027. AgileMD's hospital customers will continue to use its products, and Wolters Kluwer will work on linking them with UpToDate.
Long-term: If the combination works, hospitals could get guidelines, evidence and early-warning alerts inside one workflow. Competitors in clinical decision support may respond with their own acquisitions or partnerships.
Who is affected: Hospitals and health systems that use UpToDate or AgileMD, the doctors and nurses who use these tools, AgileMD's staff and investors, and other clinical software vendors.
What to watch next: Closing of the deal, expected in the first quarter of 2027 or sooner.
Key Takeaway
Wolters Kluwer will pay up to $100 million for AgileMD to put UpToDate's evidence and AI-based early-warning tools directly into hospitals' electronic records.
Questions and Answers
How much is Wolters Kluwer paying for AgileMD?
Up to $100 million: $40 million in cash upfront and up to $60 million in later payments that depend on performance, according to the company's announcement on 13 November 2026.
What does AgileMD do?
It makes software that turns a hospital's clinical guidelines into steps inside electronic health records, and eCART, an FDA-cleared system that predicts when hospital patients may deteriorate.
When will the Wolters Kluwer–AgileMD deal close?
In the first quarter of 2027 or sooner, subject to customary closing conditions and government approvals.
Why is Wolters Kluwer buying AgileMD?
To take its UpToDate medical evidence and AI tools beyond reference content and into the daily workflow of hospital staff, inside electronic health records.
Disclaimer: Prepared by the Peepals newsroom from publicly available sources with AI assistance. Information is accurate to the best of our knowledge at the time of publication and may change. Images may be representative. Not professional advice. Report an error via our contact page.
By Neha Kapoor, Staff WriterCovers Economy and more for Peepals Business. All stories by Neha Kapoor
MSTC share price hits 20% upper circuit on RBI TReDS nod, record Q2
UFORCE raises $700 million Series A at $6 billion valuation
Get the day's stories in your inbox
Peepals Weekly: the week decoded, free. One email a week, unsubscribe in one click.
Neha Kapoor is a pen name of the Peepals Global Editorial Team, which researches, fact-checks and publishes every story. The portrait is an illustration.
Responsible for this story: the Peepals Global Editorial Team, led by editor Prashant Sonar. How we report









